206 related articles for article (PubMed ID: 8219249)
21. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
22. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract][Full Text] [Related]
23. Current status of endocrine therapy for advanced breast cancer.
Bland KI
Ann Surg Oncol; 1999 Dec; 6(8 Suppl):4S-7S. PubMed ID: 10619452
[No Abstract] [Full Text] [Related]
24. The loss of estrogen and progesterone receptor gene expression in human breast cancer.
Lapidus RG; Nass SJ; Davidson NE
J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):85-94. PubMed ID: 10819507
[TBL] [Abstract][Full Text] [Related]
25. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
[TBL] [Abstract][Full Text] [Related]
26. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
[TBL] [Abstract][Full Text] [Related]
27. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
28. [Hormone therapy of patients with breast cancer].
Moiseenko VM; Semiglazov VF
Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
[No Abstract] [Full Text] [Related]
29. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia reduces hormone responsiveness of human breast cancer cells.
Kurebayashi J; Otsuki T; Moriya T; Sonoo H
Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer.
Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1993 Jul; 72(1):131-6. PubMed ID: 8508397
[TBL] [Abstract][Full Text] [Related]
32. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
[TBL] [Abstract][Full Text] [Related]
33. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
[TBL] [Abstract][Full Text] [Related]
34. A mutant receptor as a mechanism of drug resistance to tamoxifen treatment.
Jordan VC; Catherino WH; Wolf DM
Ann N Y Acad Sci; 1995 Jun; 761():138-47. PubMed ID: 7625717
[No Abstract] [Full Text] [Related]
35. Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer.
al-Alwan NA; al-Kubaisy W; al-Rawaq K
East Mediterr Health J; 2000; 6(2-3):475-82. PubMed ID: 11556039
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of estrogen receptor by tamoxifen in human breast cancer.
Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1993 Feb; 71(4):1266-72. PubMed ID: 8382104
[TBL] [Abstract][Full Text] [Related]
37. The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain.
Wolf DM; Jordan VC
Breast Cancer Res Treat; 1994; 31(1):129-38. PubMed ID: 7981453
[TBL] [Abstract][Full Text] [Related]
38. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
[TBL] [Abstract][Full Text] [Related]
39. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
40. Molecular aspects of estrogen receptor variants in breast cancer.
Fuqua SA; Wolf DM
Breast Cancer Res Treat; 1995 Sep; 35(3):233-41. PubMed ID: 7579493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]